🧫 Experiment Protocol
Exploratorychronic kidney diseaseACAT1Acat1 knockdown cells/tissuesproposed
Gene knockdown experiments were performed to validate the functional importance of ACAT1 in hyperoside's renoprotective effects. ACAT1 expression was reduced using molecular techniques, and the impact on hyperoside's metabolic and mitochondrial benefits was assessed. This loss-of-function approach confirmed that ACAT1 is necessary for hyperoside's therapeutic effects on fatty acid oxidation, mitochondrial function, and fibrosis reduction. The experiment provided crucial mechanistic evidence linking ACAT1 to hyperoside's mode of action.
PRIMARY OUTCOME
loss of hyperoside's metabolic and mitochondrial benefits
EXPECTED OUTCOMES
ACAT1 knockdown would abolish hyperoside's protective effects
SUCCESS CRITERIA
significant reduction in hyperoside efficacy upon ACAT1 knockdown
PROTOCOL
ACAT1 knockdown, hyperoside treatment, assessment of metabolic flux and mitochondrial function